Point72 Middle East FZE’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,549	Closed	-$1.05M	–	1026
2023 Q2	$1.05M	Buy	35,549 +24,701	+228%	+$729K	0.03%	300
2023 Q1	$250K	Buy	10,848 +7,255	+202%	+$167K	0.01%	428
2022 Q4	$99.9K	Buy	+3,593	New	+$99.9K	﹤0.01%	756